Abstract
There is an emerging need to process, expand, and even genetically engineer hematopoietic stem and progenitor cells (HSPCs) prior to administration for blood reconstitution therapy. A closed-system and automated solution for ex vivo HSC processing can improve adoption and standardize processing techniques. Here, we report a recirculating flow bioreactor where HSCs are stabilized and enriched for short-term processing by indirect fibroblast feeder coculture. Mouse 3 T3 fibroblasts were seeded on the extraluminal membrane surface of a hollow fiber micro-bioreactor and were found to support HSPC cell number compared to unsupported BMCs. CFSE analysis indicates that 3 T3-support was essential for the enhanced intrinsic cell cycling of HSPCs. This enhanced support was specific to the HSPC population with little to no effect seen with the Lineagepositive and Lineagenegative cells. Together, these data suggest that stromal-seeded hollow fiber micro-reactors represent a platform to screening various conditions that support the expansion and bioprocessing of HSPCs ex vivo.
Similar content being viewed by others
References
M. Bhatia, D. Bonnet, U. Kapp, J.C.Y. Wang, B. Murdoch, J.E. Dick, Quantitative analysis reveals expansion of human hematopoietic repopulating cells after short-term ex vivo culture. J. Exp. Med. 186, 619–624 (1997)
E. Conneally, J. Cashman, A. Petzer, C. Eaves, Expansion In Vitro of Transplantable Human Cord Blood Stem Cells Demonstrated Using a Quantitative Assay of their Lympho-Myeloid Repopulating Activity in Nonobese Diabetic–Scid/Scid Mice. Proc. of the Natl. Acad. of Sci. 94, 9836–9841 (1997)
T.R. Coughlin, G.L. Niebur, Fluid shear stress in trabecular bone marrow due to low-magnitude high-frequency vibration. J. Biomech. 45, 2222–2229 (2012)
T.A. Davis, W. Wiesmann, W. Kidwell, T. Cannon, L. Kerns, C. Serke, T. Delaplaine, A. Pranger, K.P. Lee, Effect of spaceflight on human stem cell hematopoiesis: Suppression of erythropoiesis and myelopoiesis. J. Leukoc. Biol. 60, 69–76 (1996)
A. De Leon, H. Mayani, O.T. Ramirez, Design, characterization and application of a minibioreactor for the culture of human hematopoietic cells under controlled conditions. Cytotechnology 28, 127–138 (1998)
C. Delaney, B. Varnum-Finney, K. Aoyama, C. Brashem-Stein, I.D. Bernstein, Dose-dependent effects of the notch ligand Delta1 on ex vivo differentiation and in vivo marrow repopulating ability of cord blood cells. Blood 106, 2693–2699 (2005)
C. Delaney, S. Heimfeld, C. Brashem-Stein, H. Voorhies, R.L. Manger, I.D. Bernstein, Notch-mediated expansion of human cord blood progenitor cells capable of rapid myeloid reconstitution. Nat. Med. 16, 232–236 (2010)
M.J. Domingues, S.K. Nilsson, B. Cao, New agents in HSC mobilization. Int. J. Hematol. 105, 141–152 (2017)
S.P. Dormady, X.-M. Zhang, R.S. Basch, Hematopoietic progenitor cells grow on 3T3 fibroblast monolayers that overexpress growth arrest-specific gene-6 (GAS6). Proc. Natl. Acad. Sci. 97, 12260–12265 (2000)
K. Futrega, K. Atkinson, W.B. Lott, M.R. Doran, Spheroid Coculture of hematopoietic stem/progenitor cells and monolayer expanded mesenchymal stem/stromal cells in polydimethylsiloxane microwells modestly improves in vitro hematopoietic stem/progenitor cell expansion. Tissue Engineering Part C, Methods 23, 200–218 (2017)
J.L. Gori, J.M. Butler, B. Kunar, M.G. Poulos, M. Ginsberg, D.J. Nolan, Z.K. Norgaard, J.E. Adair, S. Rafii, H.-P. Kiem, Endothelial cells promote expansion of long-term engrafting marrow hematopoietic stem and progenitor cells in primates. Stem Cells Transl. Med. 6, 864–876 (2017)
H.A. Himburg, G.G. Muramoto, P. Daher, S.K. Meadows, J.L. Russell, P. Doan, J.T. Chi, A.B. Salter, W.E. Lento, T. Reya, et al., Pleiotrophin regulates the expansion and regeneration of hematopoietic stem cells. Nat. Med. 16, 475–482 (2010)
A.A. Irani, S.S. Craig, G. Nilsson, T. Ishizaka, L.B. Schwartz, Characterization of human mast cells developed in vitro from fetal liver cells cocultured with murine 3T3 fibroblasts. Immunology 77, 136–143 (1992)
J. Kiernan, P. Damien, M. Monaghan, R. Shorr, L. McIntyre, D. Fergusson, A. Tinmouth, D. Allan, Clinical studies of ex vivo expansion to accelerate engraftment after umbilical cord blood transplantation: A systematic review. Transfus. Med. Rev. 31, 173–182 (2017)
M.R. Koller, J.G. Bender, W.M. Miller, E.T. Papoutsakis, Expansion of primitive human hematopoietic progenitors in a perfusion bioreactor system with IL-3, IL-6, and stem cell factor. Biotechnology (NY) 11, 358–363 (1993a)
M.R. Koller, S.G. Emerson, B.O. Palsson, Large-scale expansion of human stem and progenitor cells from bone marrow mononuclear cells in continuous perfusion cultures. Blood 82, 378–384 (1993b)
S. Kumar, H. Geiger, HSC niche biology and HSC expansion ex vivo. Trends Mol. Med. 23, 799–819 (2017)
M.G. Levee, G.M. Lee, S.H. Paek, B.O. Palsson, Microencapsulated human bone marrow cultures: A potential culture system for the clonal outgrowth of hematopoietic progenitor cells. Biotechnol. Bioeng. 43, 734–739 (1994)
F. Levi-Schaffer, K.F. Austen, J.P. Caulfield, A. Hein, P.M. Gravallese, R.L. Stevens, Co-culture of human lung-derived mast cells with mouse 3T3 fibroblasts: Morphology and IgE-mediated release of histamine, prostaglandin D2, and leukotrienes. J. Immunol.. (Baltimore, md: 1950) 139, 494–500 (1987)
W.C. Liles, H.E. Broxmeyer, E. Rodger, B. Wood, K. Hübel, S. Cooper, G. Hangoc, G.J. Bridger, G.W. Henson, G. Calandra, et al., Mobilization of hematopoietic progenitor cells in healthy volunteers by AMD3100, a CXCR4 antagonist. Blood 102, 2728 (2003)
N. Liu, R. Zang, S.-T. Yang, Y. Li, Stem cell engineering in bioreactors for large-scale bioprocessing. Engineering in Life Sciences 14, 4–15 (2014)
E. Lorenz, D. Uphoff, T.R. Reid, E. Shelton, Modification of irradiation injury in mice and guinea pigs by bone marrow injections. J. Natl. Cancer Inst. 12, 197–201 (1951)
W.C. Lui, Y.F. Chan, L.C. Chan, R.K. Ng, Cytokine combinations on the potential for ex vivo expansion of murine hematopoietic stem cells. Cytokine 68, 127–132 (2014)
P. Meissner, B. Schroder, C. Herfurth, M. Biselli, Development of a fixed bed bioreactor for the expansion of human hematopoietic progenitor cells. Cytotechnology 30, 227–234 (1999)
S. Méndez-Ferrer, T.V. Michurina, F. Ferraro, A.R. Mazloom, B.D. MacArthur, S.A. Lira, D.T. Scadden, A. Ma’ayan, G.N. Enikolopov, P.S. Frenette, Mesenchymal and haematopoietic stem cells form a unique bone marrow niche. Nature 466, 829–834 (2010)
S.J. Morrison, D.T. Scadden, The bone marrow niche for haematopoietic stem cells. Nature 505, 327–334 (2014)
S. Obi, K. Yamamoto, J. Ando, Effects of shear stress on endothelial progenitor cells. J. Biomed. Nanotechnol. 10, 2586–2597 (2014)
B.O. Palsson, S.H. Paek, R.M. Schwartz, M. Palsson, G.M. Lee, S. Silver, S.G. Emerson, Expansion of human bone marrow progenitor cells in a high cell density continuous perfusion system. Biotechnology (NY) 11, 368–372 (1993)
X. Pan, Q. Sun, Y. Zhang, H. Cai, Y. Gao, Y. Shen, W. Zhang, Biomimetic macroporous PCL scaffolds for ex vivo expansion of cord blood-derived CD34+ cells with feeder cells support. Macromol. Biosci. 17, 1700054 (2017)
S.R. Panch, J. Szymanski, B.N. Savani, D.F. Stroncek, Sources of hematopoietic stem and progenitor cells and methods to optimize yields for clinical cell therapy. Biol. of Blood and Marrow Transplant. 23, 1241–1249 (2017)
P. Peris, M.M. Roforth, K.M. Nicks, D. Fraser, K. Fujita, R.L. Jilka, S. Khosla, U. McGregor, Ability of circulating human hematopoietic lineage negative cells to support hematopoiesis. J. Cell. Biochem. 116, 58–66 (2015)
S. Perucca, A. Di Palma, P.P. Piccaluga, C. Gemelli, E. Zoratti, G. Bassi, E. Giacopuzzi, A. Lojacono, G. Borsani, E. Tagliafico, et al., Mesenchymal stromal cells (MSCs) induce ex vivo proliferation and erythroid commitment of cord blood haematopoietic stem cells (CB-CD34+ cells). PLoS One 12, e0172430 (2017)
J. Rak, K. Foster, K. Potrzebowska, M.S. Talkhoncheh, N. Miharada, K. Komorowska, T. Torngren, A. Kvist, Å. Borg, L. Svensson, et al., Cytohesin 1 regulates homing and engraftment of human hematopoietic stem and progenitor cells. Blood 129, 950–958 (2017)
R.A. Roberts, E. Spooncer, E.K. Parkinson, B.I. Lord, T.D. Allen, T.M. Dexter, Metabolically inactive 3T3 cells can substitute for marrow stromal cells to promote the proliferation and development of multipotent haemopoietic stem cells. J. Cell. Physiol. 132, 203–214 (1987)
C.E. Sandstrom, J.G. Bender, W.M. Miller, E.T. Papoutsakis, Development of novel perfusion chamber to retain nonadherent cells and its use for comparison of human "mobilized" peripheral blood mononuclear cell cultures with and without irradiated bone marrow stroma. Biotechnol. Bioeng. 50, 493–504 (1996)
C.A. Sardonini, Y.-J. Wu, Expansion and differentiation of human hematopoietic cells from static cultures through small-scale bioreactors. Biotechnol. Prog. 9, 131–137 (1993)
E. Schmelzer, A. Finoli, I. Nettleship, J.C. Gerlach, Long-term three-dimensional perfusion culture of human adult bone marrow mononuclear cells in bioreactors. Biotechnol. Bioeng. 112, 801–810 (2015)
E.J. Shpall, R. Quinones, R. Giller, C. Zeng, A.E. Baron, R.B. Jones, S.I. Bearman, Y. Nieto, B. Freed, N. Madinger, et al., Transplantation of ex vivo expanded cord blood. Biol. of Blood and Marrow Transplant. 8, 368–376 (2002)
J.E. Wagner, C.G. Brunstein, A.E. Boitano, T.E. DeFor, D. McKenna, D. Sumstad, B.R. Blazar, J. Tolar, C. Le, J. Jones, et al., Phase I/II trial of StemRegenin-1 expanded umbilical cord blood hematopoietic stem cells supports testing as a stand-alone graft. Cell Stem Cell 18, 144–155 (2016)
T.Y. Wang, J.K. Brennan, J.H. Wu, Multilineal hematopoiesis in a three-dimensional murine long-term bone marrow culture. Exp. Hematol. 23, 26–32 (1995)
C. Xue, K.Y.C. Kwek, J.K.Y. Chan, Q. Chen, M. Lim, The hollow fiber bioreactor as a stroma-supported, serum-free ex vivo expansion platform for human umbilical cord blood cells. Biotechnol. J. 9, 980–989 (2014)
P.W. Zandstra, C.J. Eaves, J.M. Piret, Expansion of hematopoietic progenitor cell populations in stirred suspension bioreactors of normal human bone marrow cells. Biotechnology (NY) 12, 909–914 (1994)
C.C. Zhang, M. Kaba, G. Ge, K. Xie, W. Tong, C. Hug, H.F. Lodish, Angiopoietin-like proteins stimulate ex vivo expansion of hematopoietic stem cells. Nat. Med. 12, 240–245 (2006)
E. Zonari, G. Desantis, C. Petrillo, F.E. Boccalatte, M.R. Lidonnici, A. Kajaste-Rudnitski, A. Aiuti, G. Ferrari, L. Naldini, B. Gentner, Efficient ex vivo engineering and expansion of highly purified human hematopoietic stem and progenitor cell populations for gene therapy. Stem Cell Reports 8, 977–990 (2017)
Acknowledgements
This work was supported in part by the Shriners Hospitals for Children (B.P.), National Institutes of Health Grants R01EB012521 (B.P.). BP is a founder and equity holder of Sentien Biotechnologies, Inc. whom have licensed patents pertaining to MSC and extracorporeal device-based therapeutics. The authors declare no other competing financial interests.
Author information
Authors and Affiliations
Corresponding author
Electronic supplementary material
Fig. S1
LSK proportion of scatter in 2-D transwell co-cultures for both high and low stromal doses. All values are means + standard deviation. Data is representative of three biological replicates. * indicates p-values compared to BM alone. *p < 0.05, **p < 0.01, and ***p ≤ 0.0001. (GIF 31 kb)
Fig. S2
Various flow rates on cell number and viability. All values are means + standard deviation. Data is representative of three biological replicates. * indicates p-values compared to BM alone. *p < 0.05, **p < 0.01, and ***p ≤ 0.0001. (GIF 26 kb)
Fig. S3
Raw counts and viabilities for both high and low cell-seeded models. All values are means + standard deviation. Data is representative of three biological replicates. * indicates p-values compared to BM alone. *p < 0.05, **p < 0.01, and ***p ≤ 0.0001. (GIF 47 kb)
Fig. S4
Raw counts and viabilities for both high and low stromal dose for 3 T3-seeded micro-reactors. All values are means + standard deviation. Data is representative of three biological replicates. * indicates p-values compared to BM alone. *p < 0.05, **p < 0.01, and ***p ≤ 0.0001. (GIF 45 kb)
Fig. S5
LSK proportion and cell numbers for low stromal dose model. All values are means + standard deviation. Data is representative of three biological replicates. * indicates p-values compared to BM alone. *p < 0.05, **p < 0.01, and ***p ≤ 0.0001. (GIF 49 kb)
Rights and permissions
About this article
Cite this article
Khong, D., Li, M., Singleton, A. et al. Stromalized microreactor supports murine hematopoietic progenitor enrichment. Biomed Microdevices 20, 13 (2018). https://doi.org/10.1007/s10544-017-0255-3
Published:
DOI: https://doi.org/10.1007/s10544-017-0255-3